This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/516065-johnson-vaccine-who-covid/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| Johnson & Johnson submits its single-shot Covid-19 vaccine to WHO for emergency use | Johnson & Johnson submits its single-shot Covid-19 vaccine to WHO for emergency use |
| (7 months later) | |
| Pharma giant Johnson & Johnson has submitted data on its coronavirus vaccine to the World Health Organization (WHO) as it seeks the agency’s greenlight for emergency use. Unlike other shots, this one comes in a single dose. | Pharma giant Johnson & Johnson has submitted data on its coronavirus vaccine to the World Health Organization (WHO) as it seeks the agency’s greenlight for emergency use. Unlike other shots, this one comes in a single dose. |
| The emergency-use approval is a prerequisite for the vaccine joining the WHO-led COVAX watchdog program, J&J said in a statement on Friday, revealing it had submitted its paperwork to the UN health body. | The emergency-use approval is a prerequisite for the vaccine joining the WHO-led COVAX watchdog program, J&J said in a statement on Friday, revealing it had submitted its paperwork to the UN health body. |
| Unlike vaccine competitors already in the Covid-fighting market, the J&J offering comes in a single-dose form, which would make its distribution considerably easier. Moreover, it can be stored under standard refrigerator temperatures, making it an attractive option for countries with less-developed infrastructure. | Unlike vaccine competitors already in the Covid-fighting market, the J&J offering comes in a single-dose form, which would make its distribution considerably easier. Moreover, it can be stored under standard refrigerator temperatures, making it an attractive option for countries with less-developed infrastructure. |
| While Russia’s Sputnik V, British-Swedish AstraZeneca and China’s CoronaVac vaccines can be stored in regular fridges as well, both of the US jabs by Moderna and Pfizer require extremely low temperatures to prevent spoilage. Pfizer said on Friday, however, that it had sufficient data to show its jab can actually be safely stored in a refrigerator and not the extreme cold currently advised. | While Russia’s Sputnik V, British-Swedish AstraZeneca and China’s CoronaVac vaccines can be stored in regular fridges as well, both of the US jabs by Moderna and Pfizer require extremely low temperatures to prevent spoilage. Pfizer said on Friday, however, that it had sufficient data to show its jab can actually be safely stored in a refrigerator and not the extreme cold currently advised. |
| Johnson and Johnson published data on the late-stage trials of its vaccine last month, with the solution showing a rather modest efficacy of 66 percent. The vaccine was tested across several countries and showed mixed results ranging from 72 percent in the US to merely 57 percent in South Africa. | Johnson and Johnson published data on the late-stage trials of its vaccine last month, with the solution showing a rather modest efficacy of 66 percent. The vaccine was tested across several countries and showed mixed results ranging from 72 percent in the US to merely 57 percent in South Africa. |
| So far, the J&J jab has been administered only in South Africa, and that’s after the country hastily searched for an alternative to AstraZeneca. South Africa launched its mass vaccination campaign using the AstraZeneca/Oxford University vaccine early this month, but halted it after a few days over a limited study that suggested the AstraZeneca jab fared poorly against the local and extra-contagious Covid strain. | So far, the J&J jab has been administered only in South Africa, and that’s after the country hastily searched for an alternative to AstraZeneca. South Africa launched its mass vaccination campaign using the AstraZeneca/Oxford University vaccine early this month, but halted it after a few days over a limited study that suggested the AstraZeneca jab fared poorly against the local and extra-contagious Covid strain. |
| Apart from seeking the WHO’s approval, the J&J vaccine is also expected to enter the US market shortly. The solution is currently under review by the US Food and Drug Administration, with its experts expected to discuss its emergency use authorization next week. | Apart from seeking the WHO’s approval, the J&J vaccine is also expected to enter the US market shortly. The solution is currently under review by the US Food and Drug Administration, with its experts expected to discuss its emergency use authorization next week. |
| Think your friends would be interested? Share this story! | Think your friends would be interested? Share this story! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |